Your browser doesn't support javascript.
loading
Prevalence and Predictive Factors for Upfront Dose Reduction of the First Cycle of First-Line Chemotherapy in Older Adults with Metastatic Solid Cancer: Korean Cancer Study Group (KCSG) Multicenter Study.
Hwang, In Gyu; Kwon, Minsuk; Kim, Jin Won; Kim, Se Hyun; Lee, Yun-Gyoo; Kim, Jin Young; Koh, Su-Jin; Ko, Yoon Ho; Shin, Seong Hoon; Hong, Soojung; Kim, Tae-Yong; Kim, Sun Young; Kim, Hyun Jung; Kim, Hyo Jung; Lee, Myung Ah; Kwon, Jung Hye; Hong, Yong Sang; Lee, Kyung Hee; Bae, Sung Hwa; Koo, Dong-Hoe; Kim, Jee Hyun; Woo, In Sook.
Afiliação
  • Hwang IG; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul 06973, Korea.
  • Kwon M; Department of Internal Medicine, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul 06973, Korea.
  • Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea.
  • Kim SH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea.
  • Lee YG; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea.
  • Kim JY; Department of Internal Medicine, Keimyung University Dongsan Medical Center, College of Medicine, Keimyung University, Daegu 42601, Korea.
  • Koh SJ; Department of Hematology and Oncology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Korea.
  • Ko YH; Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03476, Korea.
  • Shin SH; Department of Internal Medicine, Kosin University Gospel Hospital, Kosin University College of Medicine, Pusan 49267, Korea.
  • Hong S; Department of Internal Medicine, National Health Insurance Service Ilsan Hospital, Goyang 10444, Korea.
  • Kim TY; Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kim SY; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Kim HJ; Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon 14584, Korea.
  • Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang 14068, Korea.
  • Lee MA; Department of Internal Medicine, Seoul St. Mary's Hospital, Cancer Research Institute, The Catholic University of Korea, Seoul 06591, Korea.
  • Kwon JH; Department of Internal Medicine, Chungnam National University College of Medicine, Daejeon 35015, Korea.
  • Hong YS; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.
  • Lee KH; Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu 42415, Korea.
  • Bae SH; Department of Internal Medicine, Daegu Catholic University Hospital, Daegu Catholic University College of Medicine, Daegu 42472, Korea.
  • Koo DH; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul 03181, Korea.
  • Kim JH; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam 13620, Korea.
  • Woo IS; Division of Medical Oncology, Department of Internal Medicine, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Korea.
Cancers (Basel) ; 13(2)2021 Jan 18.
Article em En | MEDLINE | ID: mdl-33477423

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prevalence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article